Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-20

Clinical Trial Update: Interventional Bioremediation of Microbiota in Metabolic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 interventional study on microbiota bioremediation for pre-diabetes was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Minnesota | Conditions: Pre-Diabetes | Phase 2 | Status: TERMINATED | Results posted: 2020-11-20